Proteomics in hypertension and other cardiovascular diseases

References

• Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.
   PubMed Web of Science ®Google Scholar
• Dominiczak AF, Herget-Rosenthal S, Delles C, Fliser D, Fournier I, Graber A, . Systems biology to battle vascular disease. Nephrol Dial Transplant. 2010;25:1019–22.
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis. 1998;19:1853–61.
   PubMed Web of Science ®Google Scholar
• Schiffer E, Mischak H, Theodorescu D, Vlahou A. Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform. World J Urol. 2008;26: 67–74.
   PubMed Web of Science ®Google Scholar
• Schiffer E, Mischak H, Novak J. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics. 2006;6:5615–27.
   PubMed Web of Science ®Google Scholar
• Kolch W, Mischak H, Pitt AR. The molecular make-up of a tumour: proteomics in cancer research. Clin Sci (Lond). 2005;108:369–83.
   PubMed Web of Science ®Google Scholar
• Mullen W, Delles C, Mischak H. Urinary proteomics in the assessment of chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:654–61.
   PubMed Web of Science ®Google Scholar
• Mischak H, Delles C, Klein J, Schanstra JP. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis. 2010;17:493–506.
   PubMed Web of Science ®Google Scholar
• Mischak H, Massy ZA, Jankowski J. Proteomics in uremia and renal disease. Semin Dial. 2009;22:409–16.
   PubMedGoogle Scholar
• Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, . The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol. 1977;106:284–5.
   PubMed Web of Science ®Google Scholar
• Mongeau JG, Biron P, Sing CF. The influence of genetics and household environment upon the variability of normal blood pressure: the Montreal Adoption Survey. Clin Exp Hypertens A. 1986;8:653–60.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet. 2003;361:1629–41.
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Delles C, Dominiczak AF. Genetic factors in hypertension. Arch Med Sci. 2009;5(2A):S212–9.
   Google Scholar
• Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991;121:1244–63.
   PubMed Web of Science ®Google Scholar
• Tunon J, Martin-Ventura JL, Blanco-Colio LM, Lorenzo O, Lopez JA, Egido J. Proteomic strategies in the search of new biomarkers in atherothrombosis. J Am Coll Cardiol. 2010;55:2009–16.
   PubMed Web of Science ®Google Scholar
• Gerszten RE, Asnani A, Carr SA. Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. Circ Res. 2011;109:463–74.
   PubMed Web of Science ®Google Scholar
• Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, . Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med. 2010;2:46ps42.
   PubMed Web of Science ®Google Scholar
• Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, . Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem. 2005;51:1933–45.
   PubMed Web of Science ®Google Scholar
• Granger J, Siddiqui J, Copeland S, Remick D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics. 2005;5:4713–8.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Tsugawa N, Kim YO, Sanuki N, Takeda U, Lee LJ. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry. Biochem Biophys Res Commun. 2009;379:110–4.
   PubMedGoogle Scholar
• Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, . Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–9.
   PubMed Web of Science ®Google Scholar
• Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, . Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358:2107–16.
   PubMed Web of Science ®Google Scholar
• Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, . Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2006;114:201–8.
   PubMed Web of Science ®Google Scholar
• Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, . Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549–55.
   PubMed Web of Science ®Google Scholar
• Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, . Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005;67:2313–20.
   PubMed Web of Science ®Google Scholar
• Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, . Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant. 2005;5:2479–88.
   PubMed Web of Science ®Google Scholar
• Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, . Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 2006;7:230–40.
   PubMed Web of Science ®Google Scholar
• Theodorescu D, Schiffer E, Bauer HW, Douwes F, Eichhorn F, Polley R, . Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin Appl. 2008;2: 556–70.
   PubMed Web of Science ®Google Scholar
• Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, Dominiczak AF. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev. 2009;28:703–24.
   PubMed Web of Science ®Google Scholar
• Dakna M, He Z, Yu WC, Mischak H, Kolch W. Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:1250–8.
   PubMed Web of Science ®Google Scholar
• Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, . Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119: 2408–16.
   PubMed Web of Science ®Google Scholar
• Zimmerli LU, Schiffer E, Zurbig P, Good DM, Kellmann M, Mouls L, . Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics. 2008;7:290–8.
   PubMed Web of Science ®Google Scholar
• von zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, . Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res. 2009;8:335–45.
   PubMed Web of Science ®Google Scholar
• Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, Parving HH, . Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens. 2010;28:2316–22.
   PubMed Web of Science ®Google Scholar
• Delles C, Diez J, Dominiczak AF. Urinary proteomics in cardiovascular disease: Achievements, limits and hopes. Proteomics Clin Appl. 2011;5:222–32.
   PubMedGoogle Scholar
• Mullen W, Gonzalez J, Siwy J, Franke J, Sattar N, Mullan A, . A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. J Agric Food Chem. 2011;59:12850–7.
   PubMed Web of Science ®Google Scholar
• Donahue MP, Rose K, Hochstrasser D, Vonderscher J, Grass P, Chibout SD, . Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am Heart J. 2006;152:478–85.
   PubMed Web of Science ®Google Scholar
• Darde VM, de la Cuesta F, Dones FG, Alvarez-Llamas G, Barderas MG, Vivanco F. Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients? J Proteome Res. 2010;9:4420–32.
   PubMed Web of Science ®Google Scholar
• Jing L, Parker CE, Seo D, Hines MW, Dicheva N, Yu Y, . Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics. Proteomics. 2011;11:2763–76.
   PubMedGoogle Scholar
• Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, . Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond). 2010;119:335–43.
   PubMed Web of Science ®Google Scholar
• Salgado-Somoza A, Teijeira-Fernandez E, Fernandez AL, Gonzalez-Juanatey JR, Eiras S. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am J Physiol Heart Circ Physiol. 2010;299:H202–9.
   PubMed Web of Science ®Google Scholar
• You SA, Archacki SR, Angheloiu G, Moravec CS, Rao S, Kinter M, . Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics. 2003;13:25–30.
   PubMed Web of Science ®Google Scholar
• Fortuno A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, . Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens. 2004;22:2169–75.
   PubMed Web of Science ®Google Scholar
• Zalba G, Beloqui O, San Jose G, Moreno MU, Fortuno A, Diez J. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol. 2005;25:1452–7.
   PubMed Web of Science ®Google Scholar
• Barderas MG, Tunon J, Darde VM, de la Cuesta F, Duran MC, Jimenez-Nacher JJ, . Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J Proteome Res. 2007;6:876–86.
   PubMed Web of Science ®Google Scholar
• Delles C, Padmanabhan S, Lee WK, Miller WH, McBride MW, McClure JD, . Glutathione S-transferase variants and hypertension. J Hypertens. 2008;26:1343–52.
   PubMedGoogle Scholar
• McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, . Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension. 2005;45:786–92.
   PubMed Web of Science ®Google Scholar
• Wykrzykowska JJ, Garcia-Garcia HM, Goedhart D, Zalewski A, Serruys PW. Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1). Int J Cardiol. 2011;149:10–16.
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V. Genomics, proteomics and integrative “omics” in hypertension research. Curr Opin Nephrol Hypertens. 2005;14:133–9.
   PubMedGoogle Scholar
• Thongboonkerd V, Gozal E, Sachleben LR Jr, Arthur JM, Pierce WM, Cai J, . Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem. 2002;277:34708–16.
   PubMed Web of Science ®Google Scholar
• Reid JD, Holmes DT, Mason DR, Shah B, Borchers CH. Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension. J Am Soc Mass Spectrom. 2010;21:1680–6.
   PubMed Web of Science ®Google Scholar
• Grussenmeyer T, Meili-Butz S, Roth V, Dieterle T, Brink M, Winkler B, . Proteome analysis in cardiovascular pathophysiology using Dahl rat model. J Proteomics. 2011;74: 672–82.
   PubMedGoogle Scholar
• Jin X, Xia L, Wang LS, Shi JZ, Zheng Y, Chen WL, . Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics. 2006;6:1948–56.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang W, Meng X, Gao J, Wu H, Wang P, . Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan—a proteomic analysis. J Physiol Biochem. 2010;66:329–38.
   PubMedGoogle Scholar
• Gallego-Delgado J, Lazaro A, Osende JI, Esteban V, Barderas MG, Gomez-Guerrero C, . Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. J Am Soc Nephrol. 2006;17:S159–64.
   PubMed Web of Science ®Google Scholar
• Delbosc S, Haloui M, Louedec L, Dupuis M, Cubizolles M, Podust VN, . Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med. 2008;14:383–94.
   PubMed Web of Science ®Google Scholar
• Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med. 2008;18:186–94.
   PubMed Web of Science ®Google Scholar
• Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens. 2010;28:1349–55.
   PubMed Web of Science ®Google Scholar
• Carty DM, Siwy J, Brennand JE, Zurbig P, Mullen W, Franke J, . Urinary proteomics for prediction of preeclampsia. Hypertension. 2011;57:561–9.
   PubMed Web of Science ®Google Scholar
• Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, . A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics. 2009;9:2929–45.
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Zhao G, Funai EF, Harris N, Sasson IE, Bernstein IM, . Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol. 2008;199:551–16.
   PubMedGoogle Scholar
• Chen G, Zhang Y, Jin X, Zhang L, Zhou Y, Niu J, . Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. Proteomics Clin Appl. 2011;5:300–10.
   PubMed Web of Science ®Google Scholar
• Rasanen J, Girsen A, Lu X, Lapidus JA, Standley M, Reddy A, . Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. J Proteome Res. 2010;9:4274–81.
   PubMed Web of Science ®Google Scholar
• Araki Y, Nonaka D, Tajima A, Maruyama M, Nitto T, Ishikawa H, . Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins: its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertension. Proteomics. 2011;11:2727–37.
   PubMed Web of Science ®Google Scholar
• Zlatkovic J, Arrell DK, Kane GC, Miki T, Seino S, Terzic A. Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics. 2009;9:1314–25.
   PubMedGoogle Scholar
• Arrell DK, Zlatkovic LJ, Yamada S, Terzic A. K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy. Cardiovasc Res. 2011;90:258–66.
   PubMedGoogle Scholar
• Van Eyk JE. Overview: the maturing of proteomics in cardiovascular research. Circ Res. 2011;108:490–8.
   PubMed Web of Science ®Google Scholar